# Doctors attack Yuvraj Singh’s Protocol32 supplement brand

2026-11-02T08:32:34+00:00 | Health & Science | Indian Opinion Desk

Corroboration: 3 independent outlets

Doctors have criticised Yuvraj Singh's new supplement brand, Protocol32, launched on Friday (30 October), as a 'business of bad science'. Hepatologist Dr Cyriac Abby Philips, known online as TheLiverDoc, said 13 of the 32 ingredients carry documented risks of organ or mineral toxicity. He added that nearly all active ingredients lack solid scientific proof for the health benefits claimed on the label. Dr Philips called Singh 'an absolute health and science illiterate' and accused him of damaging science literacy. 'When they come together, it is going to be disastrous,' he said of the ingredients. The invite-only product, priced at Rs 4,999 for a two-month supply of 60 sachets, was co-formulated with Dr Anurag Agrawal and Dr Arpit Bansal. Singh said the 32 FSSAI-approved supplements in a single daily sachet are designed to support 13 pathways in the body. Indian Express reported Singh drew on his 2011 World Cup cancer battle in announcing the brand. The doctors said healthy adults who eat well do not need such a supplement, and mixing herbs like ashwagandha with antioxidants may harm people on other medicines or with cancer.

## Indian Opinion Analysis

Livemint and Times Now both lead with the criticism by Dr. Cyriac Abby Philips, emphasising his charge of 'business of bad science', Indian Express frames the story around Singh's own cancer-survivor narrative before reporting the backlash. The Express is the only outlet to quote Singh's full X post, including his line 'I played the World Cup with cancer,' giving the launch a personal, inspirational context that the others omit. Across all three, Dr Philips' criticism that 13 ingredients carry documented risks is uniform, as is the mention of the two co-formulating doctors. The harmonious coverage on the core safety warning suggests no major factual disagreement, only a tonal difference in whose voice opens the story. The key figure to watch for any regulatory response to the toxicity concerns remains unstated by all sources.

## Coverage

Coverage: 3 sources, 3 neutral
- livemint.com (neutral report) <https://www.livemint.com/companies/people/yuvraj-singh-launches-supplement-brand-protocol-32-theliverdoc-calls-it-in-very-bad-faith-business-of-bad-science-11793601441321.html>
  Leads with criticism by TheLiverDoc, no Singh quote
- timesnownews.com (neutral report) <https://www.timesnownews.com/health/why-is-cricketer-yuvraj-singhs-supplement-brand-marred-in-controversy-article-156450792>
  Frames as controversy, gives Singh's launch logic
- indianexpress.com (neutral report) <https://indianexpress.com/article/lifestyle/health/yuvraj-singh-supplement-brand-doctors-criticism-cancer-claims-10947002/>
  Opens with Singh's cancer story before criticism

This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry.
Update, 2 November 2026: this story now draws on 3 sources. Last updated 2026-11-02T09:46:40+00:00.

Tags: Cyriac Abby Philips, FSSAI, Protocol 32, Tata Memorial Hospital, TheLiverDoc, Yuvraj Singh
Canonical: https://indianopinion.org/yuvraj-singh-supplement-brand-protocol-32-draws-doctors-criticism/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/yuvraj-singh-supplement-brand-protocol-32-draws-doctors-criticism/#story-in-brief

How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/
